Details of the Drug

General Information of Drug (ID: DMD87T4)

• Drug Name: BNT153

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: mRNA (modRNA)
• Cross-matching ID: TTD ID: D8PJM3

References

• [1] ClinicalTrials.gov (NCT04710043) Phase I, First-in-human, Open-label, Dose Escalation Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of BNT152+153 in Patients With Solid Tumors. U.S.National Institutes of Health.